These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18848342)

  • 1. [Severe bouts of neuromyelitis optica: dramatic improvement after plasma exchanges].
    Bonnan M; Brasme H; Diaby MM; Vlaicu M; Le Guern V; Zuber M
    Rev Neurol (Paris); 2009 May; 165(5):479-81. PubMed ID: 18848342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
    Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
    Bonnan M; Valentino R; Olindo S; Mehdaoui H; Smadja D; Cabre P
    Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent plasmapheresis prevents recurrence in neuromyelitis optica.
    Miyamoto K; Kusunoki S
    Ther Apher Dial; 2009 Dec; 13(6):505-8. PubMed ID: 19954473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rescue effect of plasma exchange for neuromyelitis optica.
    Wang KC; Wang SJ; Lee CL; Chen SY; Tsai CP
    J Clin Neurosci; 2011 Jan; 18(1):43-6. PubMed ID: 20888238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.
    Watanabe S; Nakashima I; Misu T; Miyazawa I; Shiga Y; Fujihara K; Itoyama Y
    Mult Scler; 2007 Jan; 13(1):128-32. PubMed ID: 17294622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Devic's neuromyelitis optica in an infant case.
    Yuksel D; Senbil N; Yilmaz D; Yavuz Gurer YK
    J Child Neurol; 2007 Sep; 22(9):1143-6. PubMed ID: 17890418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the spectrum of neuromyelitis optica: friend or foe?
    Behbehani R
    Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
    Eichel R; Meiner Z; Abramsky O; Gotkine M
    Arch Neurol; 2008 Feb; 65(2):267-71. PubMed ID: 18268199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
    Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
    Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.
    Miao J; Aboagye DE; Chulpayev B; Liu L; Ishkanian G; Kolanuvada B; Alaie D; Petrillo RL
    Am J Case Rep; 2018 Jan; 19():41-46. PubMed ID: 29321467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange in neuromyelitis optica: a case series.
    Morgan SM; Zantek ND; Carpenter AF
    J Clin Apher; 2014 Jun; 29(3):171-7. PubMed ID: 24136389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.
    Argyriou AA; Makris N
    Acta Neurol Scand; 2008 Oct; 118(4):209-17. PubMed ID: 18336627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
    Khatri BO; Kramer J; Dukic M; Palencia M; Verre W
    J Clin Apher; 2012; 27(4):183-92. PubMed ID: 22488449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
    Merle H; Olindo S; Jeannin S; Valentino R; Mehdaoui H; Cabot F; Donnio A; Hage R; Richer R; Smadja D; Cabre P
    Arch Ophthalmol; 2012 Jul; 130(7):858-62. PubMed ID: 22776923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.
    Watanabe S; Misu T; Miyazawa I; Nakashima I; Shiga Y; Fujihara K; Itoyama Y
    Mult Scler; 2007 Sep; 13(8):968-74. PubMed ID: 17623727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A secondary progressive clinical course is uncommon in neuromyelitis optica.
    Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA; Weinshenker BG
    Neurology; 2007 Feb; 68(8):603-5. PubMed ID: 17310032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
    Jacob A; Weinshenker BG; Violich I; McLinskey N; Krupp L; Fox RJ; Wingerchuk DM; Boggild M; Constantinescu CS; Miller A; De Angelis T; Matiello M; Cree BA
    Arch Neurol; 2008 Nov; 65(11):1443-8. PubMed ID: 18779415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica in a child with atypical onset and severe outcome.
    Milani N; Zibordi F; Erbetta A; Pollo B; Angelini L
    Neuropediatrics; 2004 Jun; 35(3):198-201. PubMed ID: 15248104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.